NHV: micro-cap with distressed valuation signals and severe liquidity constraints
Intrinsic value VND 863 vs market price VND 700; implied upside 23.3% (model confidence: low).
Business Overview
Công ty Cổ phần Sức khỏe Hồi sinh Việt Nam (NHV) is listed on UPCOM with 5,480,112 shares outstanding and classified in the cyclical / Kim loại ICB grouping. Reported operating history in the past three years shows zero reported revenue (2023–2025: VND 0 bn) and essentially zero reported net profit (2023–2025: ~VND 0 bn). Total assets are reported at VND 61.2 bn (2023–2025). The balance-sheet book value per share is VND 9,661.6501 (BVPS), which the model uses as an important downside floor.
Investment Thesis
The quantitative valuation produces an intrinsic value of VND 863 per share vs the current match price of VND 700, implying a 23.3% upside, but model confidence is low and liquidity is effectively non-existent. Strengths: the P/B multiple is extremely low at 0.0621, and reported total assets of VND 61.2 bn create a tangible book-value anchor (BVPS VND 9,661.6501) that supports a floor valuation in distressed scenarios. Weaknesses: there are no reported revenues or meaningful earnings over 2023–2025 (revenue VND 0 bn; EPS ~0.0001), operating margins and ROE/ROA are effectively zero, and the P/E multiple is effectively meaningless at 5,058,564.9, reflecting near-zero EPS. Execution and liquidity risk dominate: average two-week volume is 0.0 and the trading data includes 'illiquid' and 'illiquid_upside_capped' sanity flags in the valuation model inputs. Given the model's low confidence and the company's lack of operating cash flow, the implied 23.3% upside does not sufficiently compensate for execution and marketability risk.
Valuation Commentary
EV/EBITDA mid-cycle valuation calibrated with isotonic mapping to guardrails; model treated the company as distressed and applied a BVPS floor.
- Intrinsic value per share: VND 863 (model output).
- Current market price (match price): VND 700.
- Model treats the company as distressed because of a 'negative_ebitda_bvps_floor' and enforces a BVPS floor equal to BVPS VND 9,661.6501 discounted by 0.7 in calibration.
- Calibration produced a raw intrinsic value of 6,763.2 before isotonic recalibration and capping; model confidence after recalibration: low.
- Sanity flags: illiquid and illiquid_upside_capped — upside is constrained by poor marketability.
The model-implied upside of 23.3% sits near the upper end of our moderate-upside band but comes with low confidence and explicit illiquidity caps. Because the valuation relies on distressed/bvps-floor logic rather than sustainable earnings, our conviction in the VND 863 target is limited; the price gap may reflect market skepticism about any recovery of operating activity.
Bull vs Bear
- Book-value support: BVPS reported at VND 9,661.6501 provides a tangible asset floor that underpins the calibrated distressed valuation.
- Low quoted market price (VND 700) and extremely low P/B 0.0621 imply room for re-rating should the company restart operations or crystallize asset value.
- Model-derived intrinsic value VND 863 implies 23.3% upside if marketability and execution risks are resolved.
- No reported revenue in 2023–2025 (each year: VND 0 bn) and effectively zero EPS (~0.0001) indicate the company currently lacks a visible earnings pathway.
- Severe liquidity constraints: avg_volume_2w is 0.0 and the valuation model flagged the ticker as 'illiquid' and 'illiquid_upside_capped', increasing the likelihood that holders cannot exit positions without material price impact.
- Model treats the firm as distressed (reason: 'negative_ebitda_bvps_floor'); intrinsic value is calibrated with conservative isotonic methods and low confidence, so upside may evaporate if asset recoverability is impaired.
- Top individual shareholders hold only small stakes (largest 5.43%), indicating no clear controlling sponsor with the capital capacity to execute a turnaround.
Sector Context
NHV sits in a large peer universe (385 peers) in the broader metals/cyclical grouping where median model upside is 5.6%. Top peers in the sector show materially higher model up/downside dispersion (examples: CST intrinsic VND 14,026 vs price VND 10,000; KVC intrinsic VND 1,403 vs price VND 1,000), while bottom peers can show negative double-digit implied downside. For Vietnamese micro-caps and UPCOM-listed names, VAS accounting differences, potential off-market transfers, and severely limited liquidity are common, so valuations often depend on balance-sheet recoverability or sponsor-led restructuring rather than operating cash-flow expectations. Regulators and state-investment dynamics (e.g., SOE payout mandates or SBV credit quotas) are less directly relevant for this micro-cap without bank exposures, but marketability constraints on UPCOM remain a key structural headwind.
Risk Factors
- Zero operating revenues reported in 2023–2025 (each year: VND 0 bn) — no visible earnings recovery path.
- Severe illiquidity: avg_volume_2w = 0.0 and model sanity flags 'illiquid' and 'illiquid_upside_capped' — exit risk for holders is high.
- Valuation relies on distressed/bvps-floor logic (model_inputs.distressed = true; reason = 'negative_ebitda_bvps_floor') — value realization depends on asset recovery or special transactions.
- Extremely high P/E multiple (5,058,564.9) is meaningless given near-zero EPS; earnings multiples provide no practical guidance.
- Top five shareholders are all individuals with modest stakes (largest 5.43%), increasing governance and coordination risk for any recapitalization or asset sale.
- Low model confidence (low) and calibration adjustments (isotonic mapping, raw_intrinsic_value divergence) indicate high model uncertainty.
Catalysts
- Any announcement of resumed operations or confirmed revenue contracts after a multi-year revenue hiatus.
- Corporate actions that crystallize asset value (asset sale, injection of capital, or a sponsor-led restructuring or M&A).
- Improved marketability (listing transfer to a more liquid venue or block trades to strategic investors).
- Publication of audited accounts or forensic transparency that increases confidence in reported BVPS and asset recoverability.
Forensic Assessment
No Beneish M-Score or other forensic metrics are provided (mscore: null) and no explicit red flags were reported in the forensic summary. Earnings quality is 50.0, which we view as moderate — neither strongly reassuring nor heavily suspicious. Given the lack of operating receipts and the model's distressed treatment, the principal forensic concern is limited visibility into the composition and recoverability of book assets rather than explicit manipulation indicators.
Track Record
The model's historical track record across ten years shows a hit rate of 22.2% (hit_rate = 0.2222222222222222), which is modest and implies limited reliability for directional calls in small/illiquid names. The model's average historical upside when correct is large (avg_upside_pct = 172.632) but this is driven by episodic, low-probability outcomes; with the current 'low' confidence state we treat model outputs as directional signals rather than high-conviction targets.
Written by a language model on 2026-08-11 from this page’s own model outputs and financial statements, and may quote figures from that date. Descriptive analysis, not investment advice — no buy, sell or hold recommendation is given or implied.